wherein A, X, q, R 1 , R 2a , R 2b , R 2c , R 3a , and R 3b are defined herein, useful as modulators of nuclear receptors, including Liver X receptor (LXR).
摘要:
The disclosure relates to compounds of Formulae (I)-(IX), which are formyl peptide 2 (FPR2) receptor agonists and/or formyl peptide 1 (FPR1) receptor agonists. The disclosure also provides compositions and methods of using the compounds, for example, for the treatment of atherosclerosis, heart failure, chronic obstructive pulmonary disease (COPD), and related diseases.